707 related articles for article (PubMed ID: 27259160)
21. Sorbitan monooleate and poly(L-lactide-co-epsilon-caprolactone) electrospun nanofibers for endothelial cell interactions.
Li X; Su Y; He C; Wang H; Fong H; Mo X
J Biomed Mater Res A; 2009 Dec; 91(3):878-85. PubMed ID: 19065570
[TBL] [Abstract][Full Text] [Related]
22. Enhanced bone formation in electrospun poly(L-lactic-co-glycolic acid)-tussah silk fibroin ultrafine nanofiber scaffolds incorporated with graphene oxide.
Shao W; He J; Sang F; Wang Q; Chen L; Cui S; Ding B
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():823-34. PubMed ID: 26952489
[TBL] [Abstract][Full Text] [Related]
23. Mangosteen pericarp extract embedded in electrospun PVP nanofiber mats: physicochemical properties and release mechanism of α-mangostin.
Sriyanti I; Edikresnha D; Rahma A; Munir MM; Rachmawati H; Khairurrijal K
Int J Nanomedicine; 2018; 13():4927-4941. PubMed ID: 30214198
[TBL] [Abstract][Full Text] [Related]
24. Bicomponent electrospinning to fabricate three-dimensional hydrogel-hybrid nanofibrous scaffolds with spatial fiber tortuosity.
Jin G; Lee S; Kim SH; Kim M; Jang JH
Biomed Microdevices; 2014 Dec; 16(6):793-804. PubMed ID: 24972552
[TBL] [Abstract][Full Text] [Related]
25. Controlled drug release from biodegradable thermoresponsive physical hydrogel nanofibers.
Loh XJ; Peh P; Liao S; Sng C; Li J
J Control Release; 2010 Apr; 143(2):175-82. PubMed ID: 20064568
[TBL] [Abstract][Full Text] [Related]
26. Coaxial electrospinning of (fluorescein isothiocyanate-conjugated bovine serum albumin)-encapsulated poly(epsilon-caprolactone) nanofibers for sustained release.
Zhang YZ; Wang X; Feng Y; Li J; Lim CT; Ramakrishna S
Biomacromolecules; 2006 Apr; 7(4):1049-57. PubMed ID: 16602720
[TBL] [Abstract][Full Text] [Related]
27. Attachment of nanoparticulate drug-release systems on poly(ε-caprolactone) nanofibers via a graftpolymer as interlayer.
de Cassan D; Sydow S; Schmidt N; Behrens P; Roger Y; Hoffmann A; Hoheisel AL; Glasmacher B; Hänsch R; Menzel H
Colloids Surf B Biointerfaces; 2018 Mar; 163():309-320. PubMed ID: 29329076
[TBL] [Abstract][Full Text] [Related]
28. Enhanced proliferation and osteogenic differentiation of mesenchymal stem cells on graphene oxide-incorporated electrospun poly(lactic-co-glycolic acid) nanofibrous mats.
Luo Y; Shen H; Fang Y; Cao Y; Huang J; Zhang M; Dai J; Shi X; Zhang Z
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6331-9. PubMed ID: 25741576
[TBL] [Abstract][Full Text] [Related]
29. Aligned poly(ε-caprolactone)/graphene oxide and reduced graphene oxide nanocomposite nanofibers: Morphological, mechanical and structural properties.
Ramazani S; Karimi M
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():325-34. PubMed ID: 26249597
[TBL] [Abstract][Full Text] [Related]
30. Surface modification of nanofibrous polycaprolactone/gelatin composite scaffold by collagen type I grafting for skin tissue engineering.
Gautam S; Chou CF; Dinda AK; Potdar PD; Mishra NC
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():402-9. PubMed ID: 24268275
[TBL] [Abstract][Full Text] [Related]
31. Gelatin nanoparticles loaded poly(ε-caprolactone) nanofibrous semi-synthetic scaffolds for bone tissue engineering.
Binulal NS; Natarajan A; Menon D; Bhaskaran VK; Mony U; Nair SV
Biomed Mater; 2012 Dec; 7(6):065001. PubMed ID: 23047255
[TBL] [Abstract][Full Text] [Related]
32. Core-Sheath Nanofibers as Drug Delivery System for Thermoresponsive Controlled Release.
Lv Y; Pan Q; Bligh SW; Li H; Wu H; Sang Q; Zhu LM
J Pharm Sci; 2017 May; 106(5):1258-1265. PubMed ID: 28131496
[TBL] [Abstract][Full Text] [Related]
33. PCL/PEG core/sheath fibers with controlled drug release rate fabricated on the basis of a novel combined technique.
Yu H; Jia Y; Yao C; Lu Y
Int J Pharm; 2014 Jul; 469(1):17-22. PubMed ID: 24751343
[TBL] [Abstract][Full Text] [Related]
34. Ocular biocompatibility of dexamethasone acetate loaded poly(ɛ-caprolactone) nanofibers.
Da Silva GR; Lima TH; Fernandes-Cunha GM; Oréfice RL; Da Silva-Cunha A; Zhao M; Behar-Cohen F
Eur J Pharm Biopharm; 2019 Sep; 142():20-30. PubMed ID: 31129274
[TBL] [Abstract][Full Text] [Related]
35. Electrospun essential oil-doped chitosan/poly(ε-caprolactone) hybrid nanofibrous mats for antimicrobial food biopackaging exploits.
Hasanpour Ardekani-Zadeh A; Hosseini SF
Carbohydr Polym; 2019 Nov; 223():115108. PubMed ID: 31426968
[TBL] [Abstract][Full Text] [Related]
36. Porous core/sheath composite nanofibers fabricated by coaxial electrospinning as a potential mat for drug release system.
Nguyen TT; Ghosh C; Hwang SG; Chanunpanich N; Park JS
Int J Pharm; 2012 Dec; 439(1-2):296-306. PubMed ID: 22989981
[TBL] [Abstract][Full Text] [Related]
37. [Preparation and cytocompatibility study of poly (epsilon-caprolactone)/silk sericin nanofibrous scaffolds].
Li H; Li L; Qian Y; Cai K; Lu Y; Zhong L; Liu W; Yang L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):305-9. PubMed ID: 21604491
[TBL] [Abstract][Full Text] [Related]
38. Fabrication, mechanical property and in vitro evaluation of poly (L-lactic acid-co-ε-caprolactone) core-shell nanofiber scaffold for tissue engineering.
Li T; Tian L; Liao S; Ding X; Irvine SA; Ramakrishna S
J Mech Behav Biomed Mater; 2019 Oct; 98():48-57. PubMed ID: 31195187
[TBL] [Abstract][Full Text] [Related]
39. Controlled release of a hydrophilic drug from coaxially electrospun polycaprolactone nanofibers.
Sultanova Z; Kaleli G; Kabay G; Mutlu M
Int J Pharm; 2016 May; 505(1-2):133-8. PubMed ID: 27012983
[TBL] [Abstract][Full Text] [Related]
40. Poly(ε-caprolactone)/graphene oxide biocomposites: mechanical properties and bioactivity.
Wan C; Chen B
Biomed Mater; 2011 Oct; 6(5):055010. PubMed ID: 21921319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
